Floatz logo

Therapeutic Asset Ratings

6,371 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pembrolizumab
Brain Neoplasm
Essen BiotechP3BB (65)
Pembrolizumab
Breast Carcinoma
The Netherlands Cancer InstituteP3BB (65)
Pembrolizumab
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (65)
Pembrolizumab
Cutaneous Melanoma
Melanoma Institute AustraliaP3BB (65)
Pembrolizumab
Renal Pelvis Urothelial Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
Pembrolizumab
Ureter Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
Pembrolizumab
Mucosal Melanoma
Melanoma Institute AustraliaP3BB (65)
Pembrolizumab
Primary Peritoneal Carcinoma
Roswell Park Cancer InstituteP3BB (65)
Pembrolizumab
Bladder Transitional Cell Carcinoma
Fred Hutchinson Cancer CenterP3BB (65)
Tarlatamab
Small Cell Lung Carcinoma
PrECOG, LLC.P3BB (65)
Tislelizumab
Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestP3BB (65)
Tocilizumab
Acute Chest Syndrome
Assistance Publique - Hôpitaux de ParisP3BB (65)
TRASTUZUMAB
Gastroesophageal Junction Adenocarcinoma
Boehringer IngelheimP3BB (65)
TRASTUZUMAB
Gastric Neoplasm
SUNHO（China）BioPharmaceutical CO., Ltd.P3BB (65)
Zanidatamab
HER2 Positive Breast Carcinoma
MedSIRP3BB (65)
Atezolizumab
Cutaneous Melanoma
EuroCityClinic LLCP2BB (65)
Atezolizumab
Rectal Neoplasm
Hoffmann-La RocheP2BB (65)
DARATUMUMAB
Diffuse Large B-Cell Lymphoma
AIDS Malignancy ConsortiumP2BB (65)
Dostarlimab
Stage IV Pancreatic Cancer AJCC v8
University of WashingtonP2BB (65)
Durvalumab
Intrahepatic Cholangiocarcinoma
West China HospitalP2BB (65)
Durvalumab
Fallopian Tube Carcinoma
National Cancer Institute (NCI)P2BB (65)
Epcoritamab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical CenterP2BB (65)
Epcoritamab
Small Lymphocytic Lymphoma
City of Hope Medical CenterP2BB (65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2BB (65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
University of WashingtonP2BB (65)
Showing 376 to 400 of 6,371 assets
PreviousPage 16 of 255Next